Anbin Huang
Shanxi Medical University(CN)First Hospital of Shanxi Medical University(CN)
Publications by Year
Research Areas
Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments, Systemic Lupus Erythematosus Research, Eosinophilic Disorders and Syndromes, T-cell and B-cell Immunology
Most-Cited Works
- → A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitis(2011)166 cited
- → COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study(2020)139 cited
- → An allopurinol‐controlled, multicenter, randomized, double‐blind, parallel between‐group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia(2014)72 cited
- → Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial(2020)29 cited
- → A multicenter, randomized, double-blind clinical trial of combination therapy with Anbainuo, a novel recombinant human TNFRII:Fc fusion protein, plus methotrexate versus methotrexate alone or Anbainuo alone in Chinese patients with moderate to severe rheumatoid arthritis(2012)17 cited
- → Severe pneumonia in Chinese patients with systemic lupus erythematosus(2020)13 cited
- → A randomized, controlled trial of efficacy and safety of Anbainuo, a bio-similar etanercept, for moderate to severe rheumatoid arthritis inadequately responding to methotrexate(2016)10 cited
- → Attitudes toward COVID-19 Vaccination: A Survey of Chinese Patients with Rheumatic Diseases(2022)9 cited
- → Effect of technetium-99 conjugated with methylene diphosphonate on IgM-RF, IgG-RF and IgA-RF(2003)6 cited
- → Risk Prediction for Rapidly Progressive Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis: The CRAFT Model(2023)5 cited